| 000 | 03278nam a22004095i 4500 | ||
|---|---|---|---|
| 999 |
_c361168 _d361168 |
||
| 001 | 361168 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102121329.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn nnnaamaa | ||
| 008 | 210510s2021 sz | o |||| 0|eng d | ||
| 020 | _a9783030677626 | ||
| 024 | 7 |
_a10.1007/978-3-030-67762-6 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRC848.H425 _b2021 EB |
|
| 245 | 0 | 0 |
_aHepatitis C : _bCare and Treatment : Volume 2 _cedited by Angelos Hatzakis |
| 250 | _aFirst edition 2021 | ||
| 264 | 1 |
_aCham _bSpringer International Publishing _c2021 |
|
| 300 |
_a1 recurso en línea (VI, 219 páginas) _b27 ilustraciones, 24 ilustraciones a color |
||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_aArchivo de texto _bPDF |
||
| 490 | 0 | _aBiomedical and Life Sciences (SpringerNature-11642) | |
| 490 | 0 | _aBiomedical and Life Sciences (R0) (SpringerNature-43708) | |
| 505 | 0 | _aAssessment of liver disease severity -- Hepatitis C and autoimmunity -- Extrahepatic manifestations -- Treatment indications and pretreatment assessment -- Available agents - contraindications and potential drug-drug interactions -- Current management of patients with HCV genotype 1 -- Current management of patients with HCV genotype 2 -- Current management of patients with HCV genotype 3 -- Current management of patients with HCV genotype 4 -- Current management of patients with HCV genotype 5 or 6 -- The role of RAVs in the current management of HCV -- Management of patients with HCV decompensated cirrhosis -- Management of patients with acute hepatitis C -- Management of transplant patients -- Management of immune complex-mediated manifestations of HCV -- Management of patients with co-infections (HBV, HIV) -- Management of patients under hemodialysis.-Management of active drug addicts or patients on maintenance substitution -- Management of patients with hemoglobinopathies or bleeding disorders -- Follow-up during and after treatment. | |
| 520 | 3 | _aThis volume provides the reader with a detailed overview of the current state-of-the art approach of Hepatitis C management. It reviews the course of action in handling of chronic Hepatitis C patients with various HCV genotypes and treats special cases such as acute hepatitis, transplant and renal patients as well as people who inject drugs. The two volume work on Hepatitis C introduces to the topic by reviewing virology, diagnosis, epidemiology, prevention, management and elimination of HCV. The book provides a valuable source at full length for researchers and clinicians working on Hepatitis C. | |
| 988 | _aSpringer_BiomedLife_2021 | ||
| 650 | 7 |
_2embne _aHepatitis víricas _9145703 |
|
| 700 | 1 |
_aHatzakis, Angelos. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9783030677619 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030677633 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030677640 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-67762-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b01/2022 _dz _eb _zSI |
||